Sustainability has become an increasingly urgent issue as the effects of climate change intensify and pressure builds for businesses to reduce their environmental impacts. CHPA recognizes the need to be a responsible corporate citizen and do our part to address sustainability challenges
Imposing extended producer responsibility (EPR) laws on medical device makers would be an excessive regulation given that most major companies in the industry have already implemented voluntary programs for free consumer battery recycling.
Rather than create a patchwork of statutes across jurisdictions, lawmakers should allow the comprehensive standards established by national microplastics and microbead legislation to facilitate steady industry progress on materials and waste reduction guided by science.
Regulation of Dietary Supplements covers marketing, manufacturing, labeling, and advertising enforced by FDA and the Federal Trade Commission. See these FAQs to learn more.
FDA Announcement of a proposed safety-based Administrative Order that proposes to add a skin allergy warning to labeling requirements for acetaminophen-containing drug products.
Imposing Proposition 65 state-level requirements on chemicals actively regulated under federal purview risks duplicative warnings that undermine public trust in national safety determinations. Since the FDA derives allowable limits from the best available science, overriding federal risk-benefit guidelines with California-specific thresholds triggers unnecessary labeling not reflecting real-world exposures from routine product usage shown to be safe.
The Standardized Information on Dietary Ingredients (SIDI) Work Group has released three voluntary guidelines, intended to help the dietary supplement industry comply with cGMP regulations.
